Deep brain stimulation and dopamine medication enhance ... - bioRxiv

Material in this publication may be freely quoted or reprinted, but acknowledgement is requested, together with a reference to the document ...







Identification and specification of potential ethical issues ... - ALLEA
The main question: ?Does STN DBS in patients with PD lead to cognitive decline and behavioral changes?? had not been answered properly by the studies cited.
trade and development report, 2015 | unctad
The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in ...
au-delà des symptômes moteurs de la dopamine
Interfaces placed inside the brain or body are known as internal, invasive or implanted technologies, as opposed to external, non- invasive or wearable devices.



Autres Cours:

Biobehavioural Survey Guidelines - World Health Organization (WHO)